Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 May 1;95(6):1122-1123.
doi: 10.1002/ccd.28924.

Taking the kidney to heart

Yinn Shaung Ooi  1 , William A Gray  2
Affiliations
Editorial

Taking the kidney to heart

Yinn Shaung Ooi et al. Catheter Cardiovasc Interv. .

Abstract

Growing evidence supports the role of Impella in the prevention of acute kidney injury in high-risk percutaneous interventions (HR-PCIs). The Mehran contrast-induced nephropathy risk score may serve as a helpful risk stratification tool in discerning patients undergoing HR-PCI who may benefit from renal protection with Impella support. Further research is warranted to validate this renal protection strategy.

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Tsai TT, Patel UD, Chang TI, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions. JACC Cardiovasc Interv. 2014;7(1):1-9. https://doi.org/10.1016/j.jcin.2013.06.016.
    1. O'Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012;126(14):1717-1727. https://doi.org/10.1161/CIRCULATIONAHA.112.098194.
    1. Flaherty MP, Pant S, Patel SV, et al. Hemodynamic support with a microaxial percutaneous left ventricular assist device (Impella) protects against acute kidney injury in patients undergoing high-risk percutaneous coronary intervention. Circ Res. 2017;120(4):692-700. https://doi.org/10.1161/CIRCRESAHA.116.309738.
    1. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393-1399. https://doi.org/10.1016/j.jacc.2004.06.068.

LinkOut - more resources